41.3% Return Seen to Date on SmarTrend Rogers Call (ROG)
Comtex SmarTrend(R) - Mon Dec 22, 5:04PM CST
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.49. In approximately 2 months, Rogers has returned 41.27% as of today's recent price of $78.40.
ROG: 80.02 (+1.50)
Rogers agrees to acquire Arlon
M2 - Mon Dec 22, 11:15AM CST
Rogers Corporation (NYSE: ROG) said it has signed a definitive agreement to acquire Arlon, LLC, currently owned by Handy & Harman Ltd. (NASDAQ: HNH), for USD157 million.
HNH: 45.14 (+1.73), ROG: 80.02 (+1.50)
Rogers Corporation (ROG) Soars 10% on Arlon Acquisition - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 8:21AM CST
Rogers Corporation (ROG) was a big mover last session, as the company saw its shares soar 10% on the day.
AUO: 5.42 (+0.60), ROG: 80.02 (+1.50)
Will Rogers (ROG) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 6:16AM CST
Will Rogers (ROG) Continue to Surge Higher?
ROG: 80.02 (+1.50)
NYSE stocks posting largest percentage increases
AP - Fri Dec 19, 12:25PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
EMES: 61.25 (+3.58), MIL: 6.75 (+0.01), PIR: 15.33 (-0.11), RHT: 70.92 (+0.47), ROG: 80.02 (+1.50), WTI: 7.55 (-0.12), BAS: 7.30 (-0.08)
Rogers Corporation Signs Definitive Agreement to Acquire Arlon, LLC
PR Newswire - Fri Dec 19, 10:46AM CST
Rogers Corporation (NYSE: ROG) ("Rogers" or the "Company"
HNH: 45.14 (+1.73), ROG: 80.02 (+1.50)
Rogers Shares Up 22.9% Since SmarTrend's Buy Recommendation (ROG)
Comtex SmarTrend(R) - Mon Dec 15, 11:16AM CST
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.49. In approximately 2 months, Rogers has returned 22.89% as of today's recent price of $68.20.
ROG: 80.02 (+1.50)
Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Dec 15, 7:00AM CST
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today reported its financial results for the third quarter ended September 30, 2014 and provided a corporate update.
XENE: 15.49 (+0.18), ROG: 80.02 (+1.50)
TE Connectivity's New Facility for Making Advanced Sensors - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 9:50AM CST
TE Connectivity Ltd. (TEL) inaugurated its novel state-of-the-art designing and manufacturing facility in Andover, MN.
AUO: 5.42 (+0.60), TEL: 64.59 (-0.12), ROG: 80.02 (+1.50), AVX: 14.44 (+0.05)
Shares of ROG Up 26.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Dec 01, 9:21AM CST
SmarTrend identified an Uptrend for Rogers (NYSE:ROG) on October 16th, 2014 at $55.50. In approximately 2 months, Rogers has returned 26.35% as of today's recent price of $70.12.
ROG: 80.02 (+1.50)
Should You Get Rid of Geospace Technologies (GEOS) Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 7:51AM CST
Geospace Technologies has witnessed a significant price decline in the past four weeks. The reason is negative trend in earnings estimate revisions. The stock also has seen some pretty dismal trading lately.
AUO: 5.42 (+0.60), GEOS: 26.42 (-0.61), ROG: 80.02 (+1.50), AVX: 14.44 (+0.05)
What Makes Universal Display (OLED) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 7:33AM CST
Universal Display is one such stock that can be considered to drop as it has seen negative earnings estimate revisions
AUO: 5.42 (+0.60), OLED: 27.88 (+0.06), ROG: 80.02 (+1.50), AVX: 14.44 (+0.05)
TE Connectivity Gains from Transportation Market Strength - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 10:32AM CST
The company reported a strong fourth quarter driven by strength in transportation and industrial markets.
AUO: 5.42 (+0.60), TEL: 64.59 (-0.12), ROG: 80.02 (+1.50), AVX: 14.44 (+0.05)
Cempra Poised To Join Antibacterial Drug Acquisition Buzz With Upcoming Data Release
StockMatusow - at Seeking Alpha - Tue Nov 25, 7:00AM CST
TTPH: 38.86 (+0.53), CBST: 100.29 (-0.09), ROG: 80.02 (+1.50), CEMP: 20.66 (+0.78)
BioPharm Insight Releases Hematological Cancer Report in Advance of American Society of Hematology (ASH) Annual Meeting Next Month
Business Wire - Mon Nov 24, 1:19PM CST
As the annual American Society of Hematology meeting in San Francisco approaches, the premier source for breaking news and forward-looking analysis of drug developments and forecasting data, BioPharm Insight, today released an Indication Report on the latest developments in leukemia, lymphoma and myeloma including expectations for Novartis' NVS), Kite Pharma's (NASDAQ: KITE) and Juno Therapeutics' treatments for Acute Lymphoblastic Leukemia (ALL).
SGEN: 31.10 (-0.14), KITE: 51.96 (+0.45), ROG: 80.02 (+1.50), ABBV: 66.21 (+1.86), JUNO: 39.99 (+2.71)
Geospace Technologies Corporation (GEOS) in Focus: Stock Tumbles 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 7:56AM CST
Geospace Technologies Corporation stock fell over 9% in the last trading session, showing a sharp decline yesterday at $29.54
AUO: 5.42 (+0.60), GEOS: 26.42 (-0.61), ROG: 80.02 (+1.50), AVX: 14.44 (+0.05)